PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Omada Health, Inc.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Omada Health, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.

Where $100 of sales goes

$105Operating costs$1.0Interest$4.9Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-5.2×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Higher than 55% of Healthcare companies in United States.

Cash Locked Ratio

$11

For every $100 of sales, $11 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $12 tied up three years earlier.

Less money tied up than 77% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 3/3

Sales and profit both grew in each of the last 3 years.

Steadier than 96% of Healthcare companies in United States.

Growth Efficiency Ratio

$35

Sales grew 192% in 3 years; of every extra $100 of sales, $35 became extra profit.

Higher than 61% of Healthcare companies in United States.

Asset Productivity Ratio

+192% / +38%

In 3 years sales changed by +192% while total assets changed by +38%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

No debt due

No debt falls due within a year, according to the latest yearly balance sheet.

Cash Cushion Ratio

+19%

Cash, after subtracting all debt, equals 19% of its market value (net cash).

Higher than 62% of Healthcare companies in United States.

Tangible Assets Ratio

95%

Of every $100 the company owns, $95 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 72% of Healthcare companies in United States.

Tangible Net Worth Ratio

93%

Of every $100 of net worth, $93 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 77% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+5%

Share count rose 5% in 3 years, so each share's slice of the company became smaller.

Smaller rise in share count than 74% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Omada Health, Inc. owes $0.23 for every $1 it owns. Omada Health, Inc. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

79.1

Investors pay $79.1 for every $1 of Omada Health, Inc.'s yearly profit, higher than 87% of Healthcare companies in United States.

P/B ratio

4.60

The share price is 4.60 times Omada Health, Inc.'s book value per share, higher than 70% of Healthcare companies in United States.

Market cap

$1.2 B

The total market value of all of Omada Health, Inc.'s shares at today's price (share price × number of shares), larger than 66% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$253 M

What Omada Health, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$4.13

Net worth divided by the number of shares. The share price of $18.98 is 4.6 times this, which is the P/B above.

Return on equity (ROE)

1.8%

Omada Health, Inc. earned 1.8% on its shareholders' money over the last year, higher than 77% of Healthcare companies in United States.

Owes vs Owns

0.23×

Omada Health, Inc. owes $0.23 for every $1 it owns (low), lower than 69% of Healthcare companies in United States.

Dividend yield

None

Omada Health, Inc. does not currently pay a dividend.

Revenue growth

+53%

Revenue rose 53% in the year to Dec 2025, and grew 43% a year on average over 3 years.

Profit growth

Loss

Omada Health, Inc. made a loss in each of the last two years.

Profit margin

-4.9%

Omada Health, Inc. lost $5 for every $100 of revenue.

Interest cover

Not covered

Omada Health, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

Omada Health, Inc. held $222 M more cash than debt (net cash) at Dec 2025.

Questions

What is Omada Health, Inc.'s P/E ratio?

Investors pay $79.1 for every $1 of Omada Health, Inc.'s yearly profit, higher than 87% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Omada Health, Inc.: $1.2 B ÷ $253 M (30 Jun 2026) = 4.6.

What is Omada Health, Inc.'s return on equity?

Omada Health, Inc. earned 1.8% on its shareholders' money over the last year, higher than 77% of Healthcare companies in United States.

How much does Omada Health, Inc. owe compared with what it owns?

Omada Health, Inc. owes $0.23 for every $1 it owns (low), lower than 69% of Healthcare companies in United States.

Does Omada Health, Inc. pay a dividend?

No. Omada Health, Inc. does not currently pay a dividend.

Is Omada Health, Inc.'s revenue growing?

Revenue rose 53% in the year to Dec 2025, and grew 43% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.